SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-126296
Filing Date
2024-11-13
Accepted
2024-11-13 16:05:30
Documents
63
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q ck0001534133-20240930.htm   iXBRL 10-Q 2594614
2 EX-31.1 ck0001534133-ex31_1.htm EX-31.1 15164
3 EX-31.2 ck0001534133-ex31_2.htm EX-31.2 15411
4 EX-32.1 ck0001534133-ex32_1.htm EX-32.1 9743
5 EX-32.2 ck0001534133-ex32_2.htm EX-32.2 9125
  Complete submission text file 0000950170-24-126296.txt   9219892

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT ck0001534133-20240930.xsd EX-101.SCH 1299378
66 EXTRACTED XBRL INSTANCE DOCUMENT ck0001534133-20240930_htm.xml XML 1380341
Mailing Address 505 COAST BOULEVARD SOUTH SUITE 307 LA JOLLA CA 92037
Business Address 505 COAST BOULEVARD SOUTH SUITE 307 LA JOLLA CA 92037 858-952-5500
CalciMedica, Inc. (Filer) CIK: 0001534133 (see all company filings)

IRS No.: 452120079 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39538 | Film No.: 241454052
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)